|
1.
|
Oien KA: Pathologic evaluation of unknown
primary cancer. Semin Oncol. 36:8–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Hillen HF: Unknown primary tumours.
Postgrad Med J. 76:690–693. 2000. View Article : Google Scholar
|
|
3.
|
Pavlidis N, Briasoulis E, Hainsworth J and
Greco FA: Diagnostic and therapeutic management of cancer of an
unknown primary. Eur J Cancer. 39:1990–2005. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Greco FA and Hainsworth JD: Tumors of
unknown origin. CA Cancer J Clin. 42:96–115. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Pentheroudakis G, Golfinopoulos V and
Pavlidis N: Switching benchmarks in cancer of unknown primary: from
autopsy to microarray. Eur J Cancer. 43:2026–2036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
van de Wouw AJ, Janssen-Heijnen ML,
Coebergh JW and Hillen HF: Epidemiology of unknown primary tumours;
incidence and population-based survival of 1285 patients in
Southeast Netherlands, 1984–1992. Eur J Cancer. 38:409–413.
2002.PubMed/NCBI
|
|
7.
|
Akiyama H, Tsurumaru M, Udagawa H and
Kajiyama Y: Radical lymph node dissection for cancer of the
thoracic esophagus. Ann Surg. 220:364–373. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Chen J, Liu S, Pan J, et al: The pattern
and prevalence of lymphatic spread in thoracic oesophageal squamous
cell carcinoma. Eur J Cardiothorac Surg. 36:480–486. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kelsen DP, Winter KA, Gunderson LL, et al:
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random
assignment trial comparison of chemotherapy followed by surgery
compared with surgery alone for esophageal cancer. J Clin Oncol.
25:3719–3725. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ruhstaller T, Templeton A, Ribi K, et al:
Intense therapy in patients with locally advanced esophageal cancer
beyond hope for surgical cure: a prospective, multicenter phase II
trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02).
Onkologie. 33:222–228. 2010. View Article : Google Scholar
|
|
11.
|
Cao W, Xu C, Lou G, et al: A phase II
study of paclitaxel and nedaplatin as first-line chemotherapy in
patients with advanced esophageal cancer. Jpn J Clin Oncol.
39:582–587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Shim HJ, Cho SH, Hwang JE, et al: Phase II
study of docetaxel and cisplatin chemotherapy in
5-fluorouracil/cisplatin pretreated esophageal cancer. Am J Clin
Oncol. 33:624–628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Honda M, Miura A, Izumi Y, et al:
Doxorubicin, cisplatin, and fluorouracil combination therapy for
metastatic esophageal SCC. Dis Esophagus. 23:641–645. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kim JY, Do YR, Park KU, et al: A
multi-center phase II study of docetaxel plus cisplatin as
first-line therapy in patients with metastatic squamous cell
esophageal cancer. Cancer Chemother Pharmacol. 66:31–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Overman MJ, Kazmi SM, Jhamb J, et al:
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy
for patients with advanced gastric and esophageal cancer. Cancer.
116:1446–1453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Nystrom JS, Weiner JM,
Heffelfinger-Juttner J, Irwin LE, Bateman JR and Wolf RM:
Metastatic and histologic presentations in unknown primary cancer.
Semin Oncol. 4:53–58. 1977.PubMed/NCBI
|
|
17.
|
Keskin S, Muslumanoglu M, Saip P, et al:
Clinical and pathological features of breast cancer associated with
the pathological complete response to anthracycline-based
neoadjuvant chemotherapy. Oncology. 81:30–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Untch M, Fasching PA, Konecny GE, et al:
Pathologic complete response after neoadjuvant chemotherapy plus
trastuzumab predicts favorable survival in human epidermal growth
factor receptor 2-overexpressing breast cancer: results from the
TECHNO trial of the AGO and GBG study groups. J Clin Oncol.
29:3351–3357. 2011. View Article : Google Scholar
|
|
19.
|
Okamura S, Fujiwara H, Shiozaki A, et al:
Long-term survivors of esophageal carcinoma with distant lymph node
metastasis. Hepatogastroenterology. 58:421–425. 2011.PubMed/NCBI
|
|
20.
|
Yamamoto Y, Ikeda M, Takashima M, et al: A
case of a patient with stage IVa esophageal cancer surviving over 4
years by combination chemotherapy with docetaxel, 5-FU and
cisplatin, without operation. Gan To Kagaku Ryoho. 38:1321–1324.
2011.(In Japanese).
|
